Clinical Trial Update: Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of Study Drug versus placebo for negative symptoms in schizophrenia; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED